Detalhe da pesquisa
1.
Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients.
BMJ Open
; 12(4): e061864, 2022 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35428650